🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted to determine the safety, tolerability, and ph...
Status
Completed
Location
Pacific Research Network, Inc.
Start Date
2008-10
Trial ID
NCT00766363
This study is to compare the safety and effects of donepezil (Aricept) for ...
Status
Completed
Location
Kaiser Permanente-Anaheim
Start Date
2017-05-30
Trial ID
NCT02822573
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of Aricept ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2002-10
Trial ID
NCT00630851
Treatments Being Tested
The study investigated the effects on safety and pharmacokinetics (PK) of M...
Status
Completed
Location
Woodland Research Northwest, LLC ( Site 0004)
Start Date
2021-02-16
Trial ID
NCT04308304
The study hypothesizes that donepezil will have a positive impact on brain ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01082965
This is a study to evaluate the safety, tolerability and blood levels of PF...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-12
Trial ID
NCT01028911
Treatments Being Tested
The purpose of this study was to assess the safety, tolerability, and pharm...
Status
Terminated
Location
Multiple Locations
Start Date
2016-05-05
Trial ID
NCT02769065
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of masitinib...
Status
Completed
Location
MHAT Sveta Marina
Start Date
2012-01
Trial ID
NCT01872598
Treatments Being Tested
Rosiglitazone (RSG) has been tested and is approved as a treatment for type...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02-27
Trial ID
NCT00428090
Treatments Being Tested
The purpose of this study is to determine whether scopolamine-induced cogni...
Status
Completed
Location
Multiple Locations
Start Date
2014-01
Trial ID
NCT02051335
Treatments Being Tested